Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer

Inclusion Criteria

• •1. Woman, over 18 years old.
• •2. With non-metastatic breast cancer.
• •3. Treated by hormone therapy, regardless of the molecule (cancer RH positive).
• •4. In primary prescription of hormone therapy.
• •5. First prescription by a medical oncologist, surgeon or radiation therapist from the CGFL.
• •6. Pharmacy of the patient located in the perimeter defined in the context of the study (Residents in the Burgundy region between a triangle delimited by the towns of Chatillon sur Seine, Dole and Chalon sur Saone.
• •7. Woman who received information about the study and gave her written consent.
• •8. Affiliation to a social security scheme.
• •9. Participant Agreement of the referent city pharmacy of the patient.